| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_FNDC3B_0000300 | Exon-Exon | chr3:171757418-171830380 | chr3:172039628-172112590 | 283 nt | 0.6466 |
| hsa_FNDC3B_0000400 | Exon-Exon | chr3:171757418-171851336 | chr3:172039628-172133546 | 359 nt | 0.5961 |
| hsa_FNDC3B_0000500 | Exon-Exon | chr3:171757418-171905080 | chr3:172039628-172187290 | 250 nt | 0.4080 |
| hsa_FNDC3B_0000900 | Exon-Exon | chr3:171758344-171851336 | chr3:172040554-172133546 | 286 nt | 0.5594 |
| hsa_FNDC3B_0001000 | Exon-Exon | chr3:171758344-171944737 | chr3:172040554-172226947 | 363 nt | 0.5455 |
| hsa_FNDC3B_0001100 | Exon-Exon | chr3:171758344-171965566 | chr3:172040554-172247776 | 607 nt | 0.5338 |
| hsa_FNDC3B_0001200 | Exon-Exon | chr3:171758344-171969331 | chr3:172040554-172251541 | 889 nt | 0.5219 |
| hsa_FNDC3B_0005800 | Intron-Intron | chr3:171820082-171820229 | chr3:172102292-172102439 | 148 nt | 0.4392 |
| hsa_FNDC3B_0006400 | Exon-Exon | chr3:171830242-171830380 | chr3:172112452-172112590 | 139 nt | 0.5180 |
| hsa_FNDC3B_0006500 | Exon-Exon | chr3:171830242-171851336 | chr3:172112452-172133546 | 215 nt | 0.4791 |
A study in mice demonstrated that the circFNDC3B was significantly downregulated in hearts post-myocardial infarction and in human cardiac tissues of ischemic cardiomyopathy patients, where its overexpression in cardiac endothelial cells increased vascular endothelial growth factor expression, enhanced angiogenic activity, and reduced apoptosis [Tian et al. DOI:10.3390/molecules26041155].